文献速递乳腺乳腺X线

对比增强乳腺X线摄影临床实施障碍:AJR专家小组叙述性综述

Barriers to Implementation of Contrast-Enhanced Mammography in Clinical Practice: AJR Expert Panel Narrative Review.
PubMed 文献 · AJR Am J Roentgenol · 2022-11-30

该AJR专家小组叙述性综述探讨了对比增强乳腺X线摄影(CEM)在临床推广中面临的多重障碍,包括碘对比剂风险、辐射剂量增加、部分适应症证据不足、工作流程调整、CEM引导活检系统可及性不完整以及报销困难。文中同时指出了当前或预期可缓解这些障碍的考量因素。

要点

  • CEM诊断性能优于数字乳腺X线摄影和超声,与MRI相当,但临床实施仍受限。
  • 实施障碍涉及对比剂风险、辐射、适应症证据、工作流程、活检系统及报销。
  • 文中强调了当前或预期可缓解上述障碍的考量因素。

核心结论

  • CEM临床实施受多因素限制,包括碘对比剂风险、辐射暴露增加、部分适应症证据不足、工作流程调整、CEM引导活检系统不完整及报销挑战。
  • 文中也指出了当前或预期可缓解这些障碍的考量因素。

研究设计与样本

  • 本文为AJR专家小组叙述性综述,由专家小组撰写,检索范围与纳入文献未在摘要中报告。

临床应用与阅片要点

  • 在日常阅片和报告中,需关注CEM的适应症选择,避免在证据不足或非首选的情况下使用。
  • 开展CEM需考虑工作流程调整和CEM引导活检系统的可及性。
  • 报告时应权衡碘对比剂风险和辐射暴露增加等实施障碍。

局限性

  • 本文为叙述性综述,未报告系统检索策略和纳入文献的详细情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Accumulating evidence shows that contrast-enhanced mammography (CEM) has higher diagnostic performance than digital mammography and ultrasound and comparable diagnostic performance to MRI for various indications. CEM also offers certain practical advantages for patients. Nevertheless, the clinical implementation of CEM has been limited because of a range of factors. This AJR Expert Panel Narrative Review explores such factors hindering CEM implementation. These factors include the following: the risks of iodinated contrast media, increased radiation exposure, indications for which CEM is not the preferred test or for which further evidence is needed, workflow adjustments needed when performing CEM examinations, incomplete availability of CEM-guided biopsy systems, and reimbursement challenges. Considerations that currently mitigate or are expected to mitigate these factors are also highlighted.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. van Nijnatten, Lobbes, Cozzi, et al. Barriers to Implementation of Contrast-Enhanced Mammography in Clinical Practice: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2022. PMID: 36448912. doi:10.2214/AJR.22.28567

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。